Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.500
+0.045 (1.01%)
Oct 2, 2026, 4:25 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.9 billion as of October 2, 2026. Its market cap has increased by 53.24% in one year.
Market Cap
1.90B
Enterprise Value
2.08B
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
ChartMarket Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.90B, an increase of 307.46%. That is a compound annual growth rate of 54.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.90B | 2.28% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.94B |
| Nykode Therapeutics AS | 1.13B |
| ArcticZymes Technologies ASA | 1.02B |
| Lytix Biopharma ASA | 636.73M |
| Zelluna ASA | 579.45M |
| Oncoinvent ASA | 507.43M |
| SoftOx Solutions AS | 337.71M |
| Arctic Bioscience AS | 75.48M |